Moderna, Lily, Novavax, and Pfizer stocks fall

Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary
Drug manufacturers saw their stock prices fall on Friday after vaccine skeptic Robert F. Kennedy Jr. was announced as Trump's pick for HHS.
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department
Shares of COVID vaccine manufacturers Moderna and Pfizer fell early Friday morning, down 4% and 4.3% respectively.
Pharma stocks fall as Trump picks vaccine skeptic Robert F. Kennedy Jr. for US health job
Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration.
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next head of the Department of Health and Human Services.
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Moderna stock and other vaccine shares tumbled Friday morning after Trump picked Kennedy to lead the Department of Health and Human Services.
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide.
Donald Trump nominated Robert F. Kennedy Jr., a vaccine skeptic and harsh critic of federal health agencies, to be his Secretary of Health and Human Services. Trump announced the nomination in a post on Truth Social.
Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretary
Healthcare stocks were falling Friday morning after noted anti-vaccine crusader Robert F. Kennedy Jr. was announced as President-elect Donald Trump’s pick to be the next Secretary of Health and Human Services.
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains
Shares of Novavax Inc. NVAX rose 1.39% to $7.32 Friday, on what proved to be an all-around rough trading session for the ...
Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of ...
The Trump Stock Market Bump Is Coming Down
The stock market's "Trump bump" that followed his victory over Vice President Kamala Harris in last week's election appears ...
KSL5d
FDA lifts clinical hold on Novavax's combo COVID-flu shot
The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...
AOL5d
Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals
Novavax's (NVAX) stock was trading down more than 6% Tuesday afternoon after the company lowered its guidance for sales for ...
Novavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market Outlook
Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...
Novavax’s stock slides 7% as guidance cut offsets narrower-than-expected third-quarter loss
Novavax Inc.’s stock fell 4% Tuesday after the company cut its full-year guidance, offsetting a narrower-than-expected ...
HC Wainwright Estimates Novavax’s Q3 Earnings (NASDAQ:NVAX)
Stock analysts at HC Wainwright issued their Q3 2024 earnings estimates for shares of Novavax in a note issued to investors ...